Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke

Key Points

• Dual antiplatelet therapy is found to be superior in reducing recurrent strokes, emphasizing its potential utility.
• A primary endpoint of recurrent strokes was significantly different between dual therapy and single aspirin.
• Assessment using dual antiplatelet therapy highlights its efficacy in mild to moderate ischemic strokes, although evidence remains limited and inconclusive yet compelling to explore further benefits.  The need for more robust data is apparent as dual therapies could play a crucial role in managing these patients.